Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.

Bernd Tombach; Klaus Bohndorf; Wolfgang Brodtrager; Claus D Claussen; Christoph Düber; Michael Galanski; Eckhardt Grabbe; Giacomo Gortenuti; Michael Kuhn; Walter Gross-Fengels; Renate Hammerstingl; Brigitte Happel; Gertraud Heinz-Peer; Gregor Jung; Thomas Kittner; Roberto Lagalla; Philipp Lengsfeld; Reinhard Loose; Raymond H G Oyen; Pietro Pavlica; Christiane Pering; Roberto Pozzi-Mucelli; Thorsten Persigehl; Peter Reimer; Nomdo S Renken; Götz M Richter; Ernst J Rummeny; Fritz Schäfer; Malgorzata Szczerbo-Trojanowska; Andrzej Urbanik; Thomas J Vogl; Paul Hajek

doi:10.1007/s00330-008-1054-2

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.

Bernd Tombach, Klaus Bohndorf, Wolfgang Brodtrager, Claus D Claussen, Christoph Düber, Michael Galanski, Eckhardt Grabbe, Giacomo Gortenuti, Michael Kuhn, Walter Gross-Fengels, Renate Hammerstingl, Brigitte Happel, Gertraud Heinz-Peer, Gregor Jung, Thomas Kittner, Roberto Lagalla, Philipp Lengsfeld, Reinhard Loose, Raymond H G Oyen, Pietro PavlicaChristiane Pering, Roberto Pozzi-Mucelli, Thorsten Persigehl, Peter Reimer, Nomdo S Renken, Götz M Richter, Ernst J Rummeny, Fritz Schäfer, Malgorzata Szczerbo-Trojanowska, Andrzej Urbanik, Thomas J Vogl, Paul Hajek

Institute of Radiology and Nuclear Medicine

Research output: Contribution to journal › Original Article › peer-review

23 Citations (Web of Science)

Original language	English
Pages (from-to)	2610-2619
Journal	European Radiology
Volume	18
Issue number	11
DOIs	https://doi.org/10.1007/s00330-008-1054-2
Publication status	Published - 2008

Keywords

NEPHROGENIC SYSTEMIC FIBROSIS
MAGNETIC-RESONANCE ANGIOGRAPHY
DIGITAL-SUBTRACTION-ANGIOGRAPHY
GADOLINIUM EXPOSURE
CHELATE GADOBUTROL
CONTRAST AGENT
PHARMACOKINETICS
FAILURE
DISEASE
MEDIA

Access to Document

10.1007/s00330-008-1054-2

Cite this

Tombach, B., Bohndorf, K., Brodtrager, W., Claussen, C. D., Düber, C., Galanski, M., Grabbe, E., Gortenuti, G., Kuhn, M., Gross-Fengels, W., Hammerstingl, R., Happel, B., Heinz-Peer, G., Jung, G., Kittner, T., Lagalla, R., Lengsfeld, P., Loose, R., Oyen, R. H. G., ... Hajek, P. (2008). Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. European Radiology, 18(11), 2610-2619. https://doi.org/10.1007/s00330-008-1054-2

@article{acfd4e2ea5334d2ab99f978e3cf188a3,

title = "Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.",

keywords = "NEPHROGENIC SYSTEMIC FIBROSIS, MAGNETIC-RESONANCE ANGIOGRAPHY, DIGITAL-SUBTRACTION-ANGIOGRAPHY, GADOLINIUM EXPOSURE, CHELATE GADOBUTROL, CONTRAST AGENT, PHARMACOKINETICS, FAILURE, DISEASE, MEDIA",

author = "Bernd Tombach and Klaus Bohndorf and Wolfgang Brodtrager and Claussen, {Claus D} and Christoph D{\"u}ber and Michael Galanski and Eckhardt Grabbe and Giacomo Gortenuti and Michael Kuhn and Walter Gross-Fengels and Renate Hammerstingl and Brigitte Happel and Gertraud Heinz-Peer and Gregor Jung and Thomas Kittner and Roberto Lagalla and Philipp Lengsfeld and Reinhard Loose and Oyen, {Raymond H G} and Pietro Pavlica and Christiane Pering and Roberto Pozzi-Mucelli and Thorsten Persigehl and Peter Reimer and Renken, {Nomdo S} and Richter, {G{\"o}tz M} and Rummeny, {Ernst J} and Fritz Sch{\"a}fer and Malgorzata Szczerbo-Trojanowska and Andrzej Urbanik and Vogl, {Thomas J} and Paul Hajek",

year = "2008",

doi = "10.1007/s00330-008-1054-2",

language = "English",

volume = "18",

pages = "2610--2619",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer Verlag",

number = "11",

}

Tombach, B, Bohndorf, K, Brodtrager, W, Claussen, CD, Düber, C, Galanski, M, Grabbe, E, Gortenuti, G, Kuhn, M, Gross-Fengels, W, Hammerstingl, R, Happel, B, Heinz-Peer, G, Jung, G, Kittner, T, Lagalla, R, Lengsfeld, P, Loose, R, Oyen, RHG, Pavlica, P, Pering, C, Pozzi-Mucelli, R, Persigehl, T, Reimer, P, Renken, NS, Richter, GM, Rummeny, EJ, Schäfer, F, Szczerbo-Trojanowska, M, Urbanik, A, Vogl, TJ & Hajek, P 2008, 'Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.', European Radiology, vol. 18, no. 11, pp. 2610-2619. https://doi.org/10.1007/s00330-008-1054-2

Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. / Tombach, Bernd; Bohndorf, Klaus; Brodtrager, Wolfgang et al.
In: European Radiology, Vol. 18, No. 11, 2008, p. 2610-2619.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial.

AU - Tombach, Bernd

AU - Bohndorf, Klaus

AU - Brodtrager, Wolfgang

AU - Claussen, Claus D

AU - Düber, Christoph

AU - Galanski, Michael

AU - Grabbe, Eckhardt

AU - Gortenuti, Giacomo

AU - Kuhn, Michael

AU - Gross-Fengels, Walter

AU - Hammerstingl, Renate

AU - Happel, Brigitte

AU - Heinz-Peer, Gertraud

AU - Jung, Gregor

AU - Kittner, Thomas

AU - Lagalla, Roberto

AU - Lengsfeld, Philipp

AU - Loose, Reinhard

AU - Oyen, Raymond H G

AU - Pavlica, Pietro

AU - Pering, Christiane

AU - Pozzi-Mucelli, Roberto

AU - Persigehl, Thorsten

AU - Reimer, Peter

AU - Renken, Nomdo S

AU - Richter, Götz M

AU - Rummeny, Ernst J

AU - Schäfer, Fritz

AU - Szczerbo-Trojanowska, Malgorzata

AU - Urbanik, Andrzej

AU - Vogl, Thomas J

AU - Hajek, Paul

PY - 2008

Y1 - 2008

KW - NEPHROGENIC SYSTEMIC FIBROSIS

KW - MAGNETIC-RESONANCE ANGIOGRAPHY

KW - DIGITAL-SUBTRACTION-ANGIOGRAPHY

KW - GADOLINIUM EXPOSURE

KW - CHELATE GADOBUTROL

KW - CONTRAST AGENT

KW - PHARMACOKINETICS

KW - FAILURE

KW - DISEASE

KW - MEDIA

U2 - 10.1007/s00330-008-1054-2

DO - 10.1007/s00330-008-1054-2

M3 - Original Article

C2 - 18607594

SN - 0938-7994

VL - 18

SP - 2610

EP - 2619

JO - European Radiology

JF - European Radiology

IS - 11

ER -

Tombach B, Bohndorf K, Brodtrager W, Claussen CD, Düber C, Galanski M et al. Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial. European Radiology. 2008;18(11):2610-2619. doi: 10.1007/s00330-008-1054-2